Accustem Sciences Net Income
| ACUT Stock | USD 0.58 0.02 3.33% |
As of the 2nd of February, Accustem Sciences shows the risk adjusted performance of (0.06), and Mean Deviation of 5.11. Accustem Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We are able to break down and analyze data for thirteen technical drivers for Accustem Sciences, which can be compared to its peers.
Analyzing historical trends in various income statement and balance sheet accounts from Accustem Sciences' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Accustem Sciences' valuation are summarized below:Accustem Sciences does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Accustem |
Accustem Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Accustem Sciences' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Accustem Sciences.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Accustem Sciences on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Accustem Sciences or generate 0.0% return on investment in Accustem Sciences over 90 days. Accustem Sciences is related to or competes with Telescope Innovations, Cell Source, Propanc Biopharma, and Guided Therapeutics. AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer More
Accustem Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Accustem Sciences' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Accustem Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 50.54 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 15.71 |
Accustem Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Accustem Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Accustem Sciences' standard deviation. In reality, there are many statistical measures that can use Accustem Sciences historical prices to predict the future Accustem Sciences' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | 0.8853 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Accustem Sciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Accustem Sciences February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 0.8953 | |||
| Mean Deviation | 5.11 | |||
| Coefficient Of Variation | (1,035) | |||
| Standard Deviation | 7.99 | |||
| Variance | 63.85 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | 0.8853 | |||
| Maximum Drawdown | 50.54 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 15.71 | |||
| Skewness | 0.0059 | |||
| Kurtosis | 2.72 |
Accustem Sciences Backtested Returns
Accustem Sciences secures Sharpe Ratio (or Efficiency) of -0.0674, which signifies that the company had a -0.0674 % return per unit of standard deviation over the last 3 months. Accustem Sciences exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Accustem Sciences' mean deviation of 5.11, and Risk Adjusted Performance of (0.06) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.88, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Accustem Sciences are expected to decrease slowly. On the other hand, during market turmoil, Accustem Sciences is expected to outperform it slightly. At this point, Accustem Sciences has a negative expected return of -0.54%. Please make sure to confirm Accustem Sciences' variance, as well as the relationship between the potential upside and day typical price , to decide if Accustem Sciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.42 |
Average predictability
Accustem Sciences has average predictability. Overlapping area represents the amount of predictability between Accustem Sciences time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Accustem Sciences price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Accustem Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Accustem Sciences reported net income of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.0% higher than that of the company.
Accustem Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Accustem Sciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Accustem Sciences could also be used in its relative valuation, which is a method of valuing Accustem Sciences by comparing valuation metrics of similar companies.Accustem Sciences is currently under evaluation in net income category among its peers.
Accustem Fundamentals
| Shares Owned By Insiders | 45.00 % |
About Accustem Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Accustem Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accustem Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accustem Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Accustem OTC Stock Analysis
When running Accustem Sciences' price analysis, check to measure Accustem Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accustem Sciences is operating at the current time. Most of Accustem Sciences' value examination focuses on studying past and present price action to predict the probability of Accustem Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accustem Sciences' price. Additionally, you may evaluate how the addition of Accustem Sciences to your portfolios can decrease your overall portfolio volatility.